Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 13, 2017 - Issue 12: The International Society for Vaccines 2016 Annual Congress, Boston, Oct. 2-4, 2016
Submit an article Journal homepage
2,527
Views
39
CrossRef citations to date
0
Altmetric
Research Papers

Vaccines for epidemic infections and the role of CEPI

Stanley A. PlotkinEmeritus Professor of Pediatrics, University of Pennsylvania; Vaxconsult, Doylestown, PA, USACorrespondence[email protected]
Pages 2755-2762 | Received 14 Feb 2017, Accepted 10 Mar 2017, Published online: 27 Apr 2017

Citations (39)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Kimberly M. Thompson, Dominika A. Kalkowska & Kamran Badizadegan. (2021) Hypothetical emergence of poliovirus in 2020: part 2. exploration of the potential role of vaccines in control and eradication. Expert Review of Vaccines 20:4, pages 449-460.
Read now
Irene Rivero-Calle, Jose Gómez-Rial, Louis Bont, Bradford D. Gessner, Melvin Kohn, Ron Dagan, Daniel C. Payne, Laia Bruni, Andrew J. Pollard, Adolfo García-Sastre, Denise L. Faustman, Albert Osterhaus, Robb Butler, Francisco Giménez Sánchez, Francisco Álvarez, Myrsini Kaforou, Xabier Bello & Federico Martinón-Torres. (2021) TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines. Human Vaccines & Immunotherapeutics 17:3, pages 759-772.
Read now
Tetsuro Ikegami. (2019) Candidate vaccines for human Rift Valley fever. Expert Opinion on Biological Therapy 19:12, pages 1333-1342.
Read now
Anahita Fathi, Christine Dahlke & Marylyn M. Addo. (2019) Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens. Human Vaccines & Immunotherapeutics 15:10, pages 2269-2285.
Read now
Christine C. Roberts. (2019) Emerging infectious disease laboratory and diagnostic preparedness to accelerate vaccine development. Human Vaccines & Immunotherapeutics 15:10, pages 2258-2263.
Read now

Articles from other publishers (34)

Renu Poria, Deepak Kala, Rupak Nagraik, Yashika Dhir, Sunny Dhir, Bharat Singh, Naveen Kumar Kaushik, Md Salik Noorani, Ankur Kaushal & Shagun Gupta. (2024) Vaccine development: Current trends and technologies. Life Sciences 336, pages 122331.
Crossref
Jakub Michalski, Julia Sommer, Peter Rossmanith, Anna Syguda, Tomasz Clapa & Patrick Mester. (2023) Antimicrobial and Virucidal Potential of Morpholinium-Based Ionic Liquids. International Journal of Molecular Sciences 24:2, pages 1686.
Crossref
Benjamin A. Satterfield, Chad E. Mire & Thomas W. Geisbert. 2023. Nipah Virus. Nipah Virus 1 22 .
Ebenezer Kwabena Tetteh. (2022) Assuring health commodity security in resource-poor settings. Research in Social and Administrative Pharmacy 18:3, pages 2538-2546.
Crossref
Jung-ah Choi & Jae-Ouk Kim. (2022) Middle East Respiratory Syndrome coronavirus vaccine development: updating clinical studies using platform technologies. Journal of Microbiology 60:3, pages 238-246.
Crossref
Othmann Merabet & Sylvain Baize. 2021. Antiviral Discovery for Highly Pathogenic Emerging Viruses. Antiviral Discovery for Highly Pathogenic Emerging Viruses 28 44 .
M. Lefebvre, N. Vignier, B. Pitard, E. Botelho-Nevers, B. Wyplosz, R. Cohen & O. Epaulard. (2021) COVID-19 vaccines: Frequently asked questions and updated answers. Infectious Diseases Now 51:4, pages 319-333.
Crossref
Alfonso J. Rodriguez-Morales, Alberto E. Paniz-Mondolfi, Álvaro A. Faccini-Martínez, Andrés F. Henao-Martínez, Julian Ruiz-Saenz, Marlen Martinez-Gutierrez, Lucia E. Alvarado-Arnez, Jorge E. Gomez-Marin, Ruben Bueno-Marí, Yenddy Carrero, Wilmer E. Villamil-Gomez, D. Katterine Bonilla-Aldana, Ubydul Haque, Juan D. Ramirez, Juan-Carlos Navarro, Susana Lloveras, Kovy Arteaga-Livias, Cristina Casalone, Jorge L. Maguiña, Angel A. Escobedo, Marylin Hidalgo, Antonio C. Bandeira, Salim Mattar, Jaime A. Cardona-Ospina & Jose A. Suárez. (2021) The Constant Threat of Zoonotic and Vector-Borne Emerging Tropical Diseases: Living on the Edge. Frontiers in Tropical Diseases 2.
Crossref
Patrick L F Zuber, Marion Gruber, David C Kaslow, Robert T Chen, Brigitte K Giersing & Martin H Friede. (2021) Evolving pharmacovigilance requirements with novel vaccines and vaccine components. BMJ Global Health 6:Suppl 2, pages e003403.
Crossref
Anthony E. Kiszewski, Ekaterina Galkina Cleary, Matthew J. Jackson & Fred D. Ledley. (2021) NIH funding for vaccine readiness before the COVID-19 pandemic. Vaccine 39:17, pages 2458-2466.
Crossref
Owain David Williams. (2020) COVID-19 and Private Health: Market and Governance Failure. Development 63:2-4, pages 181-190.
Crossref
Katie L. Flanagan, Emma Best, Nigel W. Crawford, Michelle Giles, Archana Koirala, Kristine Macartney, Fiona Russell, Benjamin W. Teh & Sophie CH Wen. (2020) Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines. Frontiers in Immunology 11.
Crossref
Morgan Brisse, Sophia M. Vrba, Natalie Kirk, Yuying Liang & Hinh Ly. (2020) Emerging Concepts and Technologies in Vaccine Development. Frontiers in Immunology 11.
Crossref
Kathryn M. EdwardsSonali Kochhar. (2020) Ethics of Conducting Clinical Research in an Outbreak Setting. Annual Review of Virology 7:1, pages 475-494.
Crossref
Charlene M. C. Rodrigues & Stanley A. Plotkin. (2020) Impact of Vaccines; Health, Economic and Social Perspectives. Frontiers in Microbiology 11.
Crossref
Kayvon Modjarrad & Jerome H Kim. (2020) Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?. The Lancet Infectious Diseases 20:7, pages 760-761.
Crossref
Matthew L. Boisen, Eghosa Uyigue, John Aiyepada, Katherine J. Siddle, Lisa Oestereich, Diana K. S. Nelson, Duane J. Bush, Megan M. Rowland, Megan L. Heinrich, Philomena Eromon, Adeyemi T. Kayode, Ikponmwosa Odia, Donatus I. Adomeh, Ekene B. Muoebonam, Patience Akhilomen, Grace Okonofua, Blessing Osiemi, Omigie Omoregie, Michael Airende, Jacqueline Agbukor, Solomon Ehikhametalor, Chris Okafi Aire, Sophie Duraffour, Meike Pahlmann, Wiebke Böhm, Kayla G. Barnes, Samar Mehta, Mambu Momoh, John Demby Sandi, Augustine Goba, Onikepe A. Folarin, Ephraim Ogbaini-Emovan, Danny A. Asogun, Ekaete A. Tobin, George O. Akpede, Sylvanus A. Okogbenin, Peter O. Okokhere, Donald S. Grant, John S. Schieffelin, Pardis C. Sabeti, Stephan Günther, Christian T. Happi, Luis M. Branco & Robert F. Garry. (2020) Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak. Scientific Reports 10:1.
Crossref
Stanley A Plotkin. (2020) The New Coronavirus, the Current King of China. Journal of the Pediatric Infectious Diseases Society 9:1, pages 1-2.
Crossref
Danny A. Asogun, Stephan Günther, George O. Akpede, Chikwe Ihekweazu & Alimuddin Zumla. (2019) Lassa Fever. Infectious Disease Clinics of North America 33:4, pages 933-951.
Crossref
Pierre Van Damme, Ilse De Coster, Ananda S Bandyopadhyay, Leen Suykens, Patrick Rudelsheim, Pieter Neels, M Steven Oberste, William C Weldon, Ralf Clemens & Hilde Revets. (2019) Poliopolis: pushing boundaries of scientific innovations for disease eradication. Future Microbiology 14:15, pages 1321-1330.
Crossref
Florence Kauffmann, Pierre Van Damme, Geert Leroux-Roels, Corinne Vandermeulen, Nele Berthels, Claire Beuneu & Stéphanie Mali. (2019) Clinical trials with GMO-containing vaccines in Europe: Status and regulatory framework. Vaccine 37:42, pages 6144-6153.
Crossref
Giada Mattiuzzo, Emma M. Bentley & Mark Page. (2019) The Role of Reference Materials in the Research and Development of Diagnostic Tools and Treatments for Haemorrhagic Fever Viruses. Viruses 11:9, pages 781.
Crossref
Renu Swarup, Alka Sharma & Jyoti M. Logani. (2019) Building a robust ecosystem for vaccine research in India. International Journal of Infectious Diseases 84, pages S7-S9.
Crossref
David S. Fedson. (2019) Pathogen Lists Do Not Tell Us What We Need to Do. The American Journal of Tropical Medicine and Hygiene 100:5, pages 1056-1057.
Crossref
Jean-Daniel Lelièvre. (2019) Les vaccins de demain. Revue Francophone des Laboratoires 2019:512, pages 52-63.
Crossref
Tommy Rampling, Mark Page & Peter Horby. (2019) International Biological Reference Preparations for Epidemic Infectious Diseases. Emerging Infectious Diseases 25:2, pages 205-211.
Crossref
Laura T Mazzola & Cassandra Kelly-Cirino. (2019) Diagnostics for Lassa fever virus: a genetically diverse pathogen found in low-resource settings. BMJ Global Health 4:Suppl 2, pages e001116.
Crossref
Rodolphe Pelissier, Mathieu Iampietro & Branka Horvat. (2019) Recent advances in the understanding of Nipah virus immunopathogenesis and anti-viral approaches. F1000Research 8, pages 1763.
Crossref
Igor S. Lukashevich, Slobodan Paessler & Juan Carlos de la Torre. (2019) Lassa virus diversity and feasibility for universal prophylactic vaccine. F1000Research 8, pages 134.
Crossref
Trevor V. Gale, Timothy M. Horton, Andrew R. Hoffmann, Luis M. Branco & Robert F. Garry. (2018) Host Proteins Identified in Extracellular Viral Particles as Targets for Broad-Spectrum Antiviral Inhibitors. Journal of Proteome Research.
Crossref
Matthew L. Boisen, Jessica N. Hartnett, Jeffrey G. Shaffer, Augustine Goba, Mambu Momoh, John Demby Sandi, Mohamed Fullah, Diana K. S. Nelson, Duane J. Bush, Megan M. Rowland, Megan L. Heinrich, Anatoliy P. Koval, Robert W. Cross, Kayla G. Barnes, Anna E. Lachenauer, Aaron E. Lin, Mahan Nekoui, Dylan Kotliar, Sarah M. Winnicki, Katherine J. Siddle, Michael Gbakie, Mbalu Fonnie, Veronica J. Koroma, Lansana Kanneh, Peter C. Kulakosky, Kathryn M. Hastie, Russell B. Wilson, Kristian G. Andersen, Onikepe O. Folarin, Christian T. Happi, Pardis C. Sabeti, Thomas W. Geisbert, Erica Ollmann Saphire, S. Humarr Khan, Donald S. Grant, John S. Schieffelin, Luis M. Branco & Robert F. Garry. (2018) Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever. Scientific Reports 8:1.
Crossref
Barney S. Graham & Nancy J. Sullivan. (2017) Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic. Nature Immunology 19:1, pages 20-28.
Crossref
Elizabeth S. Higgs, Sheri A. Dubey, Beth A. G. Coller, Jakub K. Simon, Laura Bollinger, Robert A. Sorenson, Barthalomew Wilson, Martha C. Nason & Lisa E. Hensley. 2017. Marburg- and Ebolaviruses. Marburg- and Ebolaviruses 229 261 .
Ana Santos Rutschman. (2020) Intellectual Property as a Determinant of Health. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.